Predicting New Chemistry: Impact of High-Quality Training Data on Prediction of Reaction Outcomes

Scientists at Bayer expand their understanding into new, useful chemistry by improving the predictive power of a synthesis planning model with scientist-curated reactions from CAS.

Understanding the nanotechnology in COVID-19 vaccines

Lipid nanoparticles are a vital component of the new Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, by protecting and transporting the mRNA effectively to the right place in cells.

Do other vaccines protect you from COVID-19?

Research has revealed correlations between COVID-19 severity and a patient’s vaccination history.

Structurally Novel Small Molecule Drugs Outperformed in 2020 – Infographic

Download this CAS infographic to see structures and information about new structurally novel small molecule drugs approved by the FDA in 2020.

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation

Avoiding Costly IP Missteps: Insights for high-quality due diligence searches

Optimizing our “new normal” to achieve exceptional innovation in 2021 and beyond

ICL Discovers New Uses for Waste Compounds with Better Data Connections  

Repurposing chemicals requires first uncovering the right insights from vast amounts of research. This case study shows how CAS enabled the efficient discovery of application leads for 75% of ICL’s target byproduct compounds.

Oh, what a year it’s been! Lessons learned amid the pandemic